glp-1 without diabetes Semaglutide Shows Secondary Cardiovascular Prevention Benefits in Patients GLP-1 RAs, Other Agents, Underused

JCI Insight

Research has demonstrated that non-diabetic patients using Ozempic can lose an average of 10-15% of their body weight over a year

Lab Testing During Treatment To ensure the safe and effective use of GLP-1 receptor agonists, we recommend regular lab testing to monitor liver, kidney, pancreatic, blood sugar and micronutrients levels

Poor sleep tanks your willpower, increases hunger hormones (ghrelin), decreases satiety hormones (leptin), and makes you crave high-calorie foods

WHAT IS DIARRHEA

Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials Hypertension is strongly associated with increased body weight